Evidence method
Level · gp.fundamentals.debt_to_revenue
354.76% · OPTIONAL · VALID
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME
ANIP · Sep 30, 2020
ANI PHARMACEUTICALS INC. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration
State dimensions
Filing0001023024-20-000008General Corporate
Evidence method
Level · gp.fundamentals.capex_revenue_ratio
3.32% · OPTIONAL · VALID
Evidence method
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-3.05% · OPTIONAL · VALID
Evidence method
Yoy · gp.fundamentals.revenue
3.20% · CORE · VALID
Evidence method
Level · gp.fundamentals.inventory_revenue_ratio
111.73% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.gross_margin
62.03% · CORE · VALID
Evidence method
Level · gp.fundamentals.operating_margin
5.29% · CORE · VALID
Evidence method
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
5.55% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.sbc_revenue_ratio
4.50% · OPTIONAL · VALID
As-filed lineage
Fundamental state history
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History49 statesSelf-history eligible
Sep 30, 20218/8 normalizedLevel 3Dec 31, 20218/8 normalizedLevel 3Mar 31, 20228/8 normalizedLevel 3Jun 30, 20228/8 normalizedLevel 3Sep 30, 20228/8 normalizedLevel 3Dec 31, 20228/8 normalizedLevel 3Mar 31, 20238/8 normalizedLevel 3Jun 30, 20238/8 normalizedLevel 3Sep 30, 20238/8 normalizedLevel 3Dec 31, 20238/8 normalizedLevel 3Mar 31, 20248/8 normalizedLevel 3Jun 30, 20248/8 normalizedLevel 3Sep 30, 20248/8 normalizedLevel 3Dec 31, 20248/8 normalizedLevel 3Mar 31, 20258/8 normalizedLevel 3Jun 30, 20258/8 normalizedLevel 3Sep 30, 20258/8 normalizedLevel 3Dec 31, 20258/8 normalizedLevel 3Mar 31, 20268/8 normalizedLevel 3Jun 30, 20268/8 normalizedLevel 4
Period transition
What moved in the state?
- Previous
- 392.42%
- Current
- 354.76%
- Delta
- -37.67%
- Previous
- 1.50%
- Current
- 3.32%
- Delta
- 1.83%
- Previous
- 43.08%
- Current
- -3.05%
- Delta
- -46.12%
- Previous
- -10.83%
- Current
- 3.20%
- Delta
- 14.03%
- Previous
- 108.44%
- Current
- 111.73%
- Delta
- 3.29%
- Previous
- 57.30%
- Current
- 62.03%
- Delta
- 4.72%
- Previous
- -23.33%
- Current
- 5.29%
- Delta
- 28.62%
- Previous
- 6.26%
- Current
- 5.55%
- Delta
- -0.71%
- Previous
- 11.83%
- Current
- 4.50%
- Delta
- -7.34%
Self-history only
Previous similar states
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research
Transitioned To · ANIP Fundamental State →Transitioned To · ANIP Fundamental State →Transitioned To · ANIP BALANCE_SHEET_LEVERAGE_DECREASED →Transitioned To · ANIP CAPEX_INTENSITY_INCREASED →Transitioned To · ANIP CASH_GENERATION_DECREASED →Transitioned To · ANIP GROWTH_INCREASED →Transitioned To · ANIP INVENTORY_PRESSURE_INCREASED →Transitioned To · ANIP MARGIN_INCREASED →Transitioned To · ANIP PROFITABILITY_INCREASED →Transitioned To · ANIP R_AND_D_INTENSITY_DECREASED →Transitioned To · ANIP SBC_INTENSITY_DECREASED →
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.